Search
for
Sort by
Research 151–180 of 1000+
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Systemic treatments for alopecia areata: A systematic review
- Tofacitinib therapy for children with severe alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- The Pathogenesis of Alopecia Areata in Rodent Models
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- The Functional Relevance of the Type 1 Cytokines IFN-γ and IL-2 in Alopecia Areata of C3H/HeJ Mice
- The treatment of alopecia areata
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- A review on laser and light-based therapies for alopecia areata
- Alopecia areata masquerading as frontal fibrosing alopecia
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Novel therapies for alopecia areata: The era of rational drug development
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Current and future pharmacotherapy for alopecia areata
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata